As the first such division of our kind in the country, Endocrine Surgery at Michigan enjoys a strong legacy of advancements in the field. One of the our department’s greatest chairmen was Frederick A. Coller, M.D., a renowned thyroid surgeon and the namesake of the Coller Surgical Society. Today, we perform more than 1,000 endocrine surgery procedures each year, making us one of the most experienced teams in the country. Through our research, we’re advancing understanding of how cancers develop, and through our training programs, we emphasize independence and in-depth learning to produce excellent future endocrine surgeons.
Our clinical philosophy is threefold: Assemble the best multidisciplinary teams; harness the power of technology; and deliver effective and proven surgical techniques with compassion.
Our clinical specialties include:
- Parathyroid disease: We’ve performed more than 3,500 parathyroid operations since 2000, offering treatment for both routine cases and the most advanced form of the disease. We’ve developed advanced techniques for monitoring parathyroid hormone production during surgery, and use both minimally invasive and open surgical approaches.
- Thyroid disease: As one of the largest endocrine surgical divisions in the U.S., our surgeons perform more than 500 thyroid surgeries a year, with a track record of lower complication rates and optimal patient outcomes.
- Adrenal disease: In their entire career, most doctors will never encounter a single case of adrenal cancer. University of Michigan adrenal specialists typically see 10 to 15 adrenal cancer patients each week. Our surgeons offer treatment for common conditions and the most advanced types of adrenal disease, including: adrenal cancer, Cushing's syndrome, adrenal nodules, and adrenal tumors.
- Endocrine cancer: The Multidisciplinary Endocrine Tumor Program at the University of Michigan is composed of endocrinologists, endocrine surgeons, radiologists, nuclear medicine specialists and oncologists who specialize in all aspects of diagnosis and treatment of endocrine conditions, including: familial neuroendocrine syndromes, pancreatic neuroendocrine tumors, and carcinoid and intestinal neuroendocrine tumors.